Cannabiz co-founder Martin Lane and editor-at-large Rhys Cohen are back with their take on the week’s cannabis news, including:

  • Who to blame for this week’s media coverage of over-the-counter CBD
  • What the Narcotic Drugs Amendment Bill means for the Australian industry
  • Where the next US$7.2 billion cannabis company will come from
  • And what David Beckham could learn from the Cannabiz team’s skincare regime

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Join or login
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...

Join the Conversation

1 Comment

  1. Thanks guys. Interesting discussion. Didn’t know about Jazz pharma buy out of GW. Any link with Entoura/Incannex? Seems they have similar research interests in sleep disorders and BMT.